NCBI Summary
This gene encodes the carbohydrate-binding protein malectin which is a Type I membrane-anchored endoplasmic reticulum protein. This protein has an affinity for Glc2Man9GlcNAc2 (G2M9) N-glycans and is involved in regulating glycosylation in the endoplasmic reticulum. This protein has also been shown to interact with ribophorin I and may be involved in the directing the degradation of misfolded proteins. Alternate splicing results in multiple transcript variants. [provided by RefSeq, Jan 2015].
Protein
Protein (NP_055545)
Malectin
Malectin
MLEC
malectin
Undefined
Curated
Malectin
Undefined
b-sandwich / ConA-like
Glc(2)Man(9)GlcNAc(2)
0.925
Protein sequence and protein families (fasta) (292 amino acids) Download
MLGAWAVEGTAVALLRLLLLLLPPAIRGPGLGVAGVAGAAGAGLPESVIWAVNAGGEAHVDVHGIHFRKDPLEGRVGRASDYGMKLPILRSNPEDQILYQTERYNEETFGYEVPIKEEGDYVLVLKFAEVYFAQSQQKVFDVRLNGHVVVKDLDIFDRVGHSTAHDEIIPMSIRKGKLSVQGEVSTFTGKLYIEFVKGYYDNPKVCALYIMAGTVDDVPKLQPHPGLEKKEEEEEEEEYDEGSNLKKQTNKNRVQSGPRTPNPYASDNSSLMFPILVAFGVFIPTLFCLCRL
Mol* PDB structure viewer

Either no PDB or existing PDB of non-glycosylated form

Structural models
Model Confidence:
  •    Very high (pLDDT > 90)
  •    Confident (90 > pLDDT > 70)
  •    Low (70 > pLDDT > 50)
  •    Very low (pLDDT < 50)

  AlphaFold produces a per-residue confidence score (pLDDT) between 0 and 100. Some regions with low pLDDT may be unstructured in isolation.


SWISS-MODEL structural models
Ligand
Glycan ligands from structural data
No crystal structures of complexes with glycan ligand.
References
NCBI References (10 PubMed Identifiers)
  • Cryo-electron microscopy structures of human oligosaccharyltransferase complexes OST-A and OST-B. [31831667]
  • Histone Interaction Landscapes Visualized by Crosslinking Mass Spectrometry in Intact Cell Nuclei. [30021884]
  • Malectin gene polymorphisms promote cerebral palsy via M2-like macrophage polarization. [28972276]
  • Association of malectin with ribophorin I is crucial for attenuation of misfolded glycoprotein secretion. [25451265]
  • Malectin forms a complex with ribophorin I for enhanced association with misfolded glycoproteins. [22988243]
  • Role of malectin in Glc(2)Man(9)GlcNAc(2)-dependent quality control of alpha1-antitrypsin. [21813736]
  • MicroRNAs and target site screening reveals a pre-microRNA-30e variant associated with schizophrenia. [20347265]
  • Malectin: a novel carbohydrate-binding protein of the endoplasmic reticulum and a candidate player in the early steps of protein N-glycosylation. [18524852]
  • Getting in and out from calnexin/calreticulin cycles. [18303019]
  • The heterodimeric structure of glucosidase II is required for its activity, solubility, and localization in vivo. [10929008]
UniProt Main References (5 PubMed Identifiers)
  • Prediction of the coding sequences of unidentified human genes. IV. The coding sequences of 40 new genes (KIAA0121-KIAA0160) deduced by analysis of cDNA clones from human cell line KG-1. [8590280]
  • The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC). [15489334]
  • Initial characterization of the human central proteome. [21269460]
  • An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome. [24275569]
  • N-terminome analysis of the human mitochondrial proteome. [25944712]
All isoforms of this gene containing a lectin domain
NP_055545.1, NP_001290556.1, XP_011537333.1, XP_011537334.1, NP_001290557.1
RNA
RNA (Transcript ID: NM_014730.4)
malectin, transcript variant 1
m7G-5')ppp(5'-GUGGCUGAGAAGAAGGAGGCCUGAGAGCGACAUGUCCCCGGCGGCUCAGGCGGAGCGGCCCGUGGCGCUGUUUUUCUGAGUCCGGGGUGGCCUGGCAGCCGGCCGAGGACGAGGGUCGGCGGGGGCUGCCCCCGUGGUGGUGGCCGCCAUGCUGGGAGCCUGGGCGGUUGAGGGAACCGCUGUGGCGCUCCUGCGACUGCUGCUGCUGCUGCUGCCGCCGGCGAUCCGGGGACCCGGGCUCGGCGUGGCCGGCGUGGCCGGCGCGGCGGGGGCCGGGCUGCCCGAGAGCGUCAUUUGGGCGGUCAACGCGGGUGGAGAGGCGCAUGUGGACGUGCACGGGAUCCACUUCCGCAAGGACCCUUUGGAAGGCCGGGUGGGCCGAGCCUCAGACUAUGGCAUGAAACUGCCAAUCCUGCGUUCCAACCCUGAGGACCAGAUCCUGUAUCAAACUGAGCGGUACAAUGAGGAGACCUUUGGCUACGAAGUGCCCAUCAAAGAGGAGGGGGACUACGUGCUGGUCUUGAAAUUUGCAGAGGUCUACUUUGCACAGUCCCAGCAAAAGGUAUUUGAUGUACGAUUGAAUGGCCACGUCGUGGUGAAGGACUUGGAUAUCUUUGAUCGUGUUGGGCAUAGCACAGCUCACGAUGAAAUUAUACCUAUGAGCAUCAGAAAGGGGAAGCUGAGUGUCCAGGGGGAGGUGUCCACCUUCACAGGGAAACUCUACAUUGAGUUUGUCAAGGGGUACUAUGACAAUCCCAAGGUCUGUGCACUCUACAUCAUGGCUGGGACAGUGGAUGAUGUACCAAAGCUUCAGCCUCAUCCGGGAUUGGAGAAGAAAGAAGAGGAAGAAGAAGAAGAAGAAUAUGAUGAAGGGUCUAAUCUCAAAAAACAGACCAAUAAGAACCGGGUGCAGUCAGGCCCCCGCACACCCAACCCCUAUGCCUCGGACAACAGCAGCCUCAUGUUUCCCAUCCUGGUGGCCUUCGGAGUCUUCAUUCCAACCCUCUUCUGCCUCUGCCGGUUGUGAGAACAAAUGACUAUCCUGAACAGGGUGGAGGGGUGUGGGAAAGAAACCAGCCAUAUUGGUUUUGGUUUCUGUAUUUUUCACAAUGAUUAAUGAACAAAAACAAAGAGAAAAAAACACACAUCAAUUAAAGGAGACAAAAAGAGGCAGAGCGAGUAGAGAGCAGCCCUCAUUCACCACCUGGUCCCAGACGUGCUUCAGUCCUCGUCCUCUCUUUGUGGCUGGCUCCCAGCCUUCUCUUUCCUCUUGAGGAUACUUAGGGUAAACUGGAUCCUUCCUGCUCAAGGAUCCUCAUUUGUAUACCUAGUGGAAAGGACUCUGAACUCAGAGGAGUCACUGUUCCUUUUUUUAGGUUAGAAAUUAACAGCAGGGAAAUGCCAUCUUAUUACCUGAGACGACCAGCACUGGGAGUUAGGUACGGUCUGAAGUUAUGUCUAGAUAAGACUUCAGACGUCCUGGGAUUGAAAGAAUGUGUGUGAAGGGGUAGAAUUUGUGCGGUAAAGACUUAAAAAAAAAAGUAGGGAGAUUAAAAAAAAAGAAAGAAAAUGCUUCCUUAUCUGGAAGCCUUUCUGGAUUAAUCCAGUGAUGGUCCCACCUUUAGUGUUUGAGCUUUGUCAUUGCUUGUCUCCCUGGCAUGUGCCAGUUAUAGACUGUCCAGCAUCCAAGACGUUUCGGUUAUGUCGGGUCCUCAGAUCGCCUCUGACUUGUUACCACAACAAAUCAUUUUGAUUUCAGUGCCUGUUGGGGACUUGAUUUCUUCUCAGUUUUGUUUGUUUGUUUGUUUCCUUAAUCUGGCUCAUUUGAAAUUUCUUCUCCCUCUCAACCAUCCCACUAAGUUAUAGCCAAGAAGGGAAGGAGACACGGGGAUUUGGGGUUCUCUGCUUGAAUGUCUUCUCCUUUACCACCUCACCUUGUUGGUACCUCCCUCCCUGGAUCUCUGAGCCAGCAGCCAGGAGGACCUGACCCAGCAGUUCUUUACUGGCCCCUUUGUAGGGCCUUGCUGCCAGGGGGCAGGGAUGCUUUCCAGCCUGCAGCAACAGAACACUUGACCUUAAAAGUCUCUUCUGGUCUUUGGAUUAGAAAAGGCUUAUGUUAGCAUAGCUUAAGAGCAACCUCAGAGAUUUGAGCCCUACUAAGUGACUGACCACUGUUUAGAGUGUCUGGUAUCUGAUGUUCAUUUAUUCCCAUGUUCUUGUGUGUCACAGUUCAGCCAGUUUUGGUUUAUGCCUAGAGCUACUUCAAGGAACUAGACUAAUUAGCUAUAUAGGCCCAGCGAUGCUUCUUAUUGAUCUUAAUAGUAUGCCCCUCCUUCCCCUGUCCUUUCAUUUCUCUAUCCAAGUAGCAGUCAGGUUCUUGGUGUGAUGGGACUGAAAGAAUUCCAGUCAGCCAGAGCCUUGGCAGCUCUGAAGCUAACCUUAGCAUCUAAGUGUCGAUCUUGAAUUCCCUGAAAAAAUUUCUAUAGGAAAUGAAGCUUCCCUGGUCCCCUCCUUUCUGGCCAUUGUCAUCCAUUUCCCAGUUAGGGCAACAAUGAAGGAGGACCCAGCCAAGCUAGAAGGAAUUUUGUGGAUGGGAGACAGCAGGAUUAGCUUCAGCUUGGGCUGGAGCAGUCAAUAUAGGAUCUCAGGCCAGGCCCGCUUUUCUAGAAUGUGUUUAAUUUUGAGUUUGCUUUAUUAGAUAUGUUUUUUAAGAGCUCUGUAUAUUUGAACUGCUCCUUAUGUGACAAAAUAGGUAGCUCUUGGGCUCAUGUCCUGGGUUUUGGCUCUUUAAUGAUUACUCCAGGCCAGCAUUUAGUCGUUUGAGAAUUGUAGCCUGUUGUUUUCGCUGUGACUUGGGUCUCAGUGCUAGGGUAUUGAGUCAGGCAGCUGGAGGGUUGUGGCCCGAGGCUGCAGUCAGAGGUAUACUUCCCAUAGUGCUUCACACAGCUCCCCUGCUUCUAAAGGAUAAGGUACUGUAGCCUUGGUCCUGGGGACCACCUGCCUGGGGCAGUGGACAUCCUAACUAAACAGGCUUCUGGCAGUAGCUUUGGUUCCUAUCCCAUCGAAAUUCCCCAAAGCCCUGGGCCACUGCCAUUGGGUUAGUCAAGAUGAAGGAGGAGGACUGGCUGCCUCCAUUUUGCCUUGUUUGUUAGUUUGCCUGGGUCUGUCUGAGGAAGGAGGGGGUCCCGCCUUCCACCUCAACACAUCCCUUCAGUGACUCAGAGUCUCAGAAGGAAACCCUGACUCCUGGGGCCAUUUCCUAAUGGUACUGUAAGCCAAGCAGCUUUGCUUCUGCCUCUGUUUCCAAGCCCACCCUUUUCCCCUGAGCUCAGGGUUAGGGAUGGGCGCUUUCCUCUCUGGUUGUGAACGAAAGGAAGGAACAUCUUUCUAUGGCUAACAAAAACUAAAGGGGAAGUGAGGAAACAGGAAGAAGUAUGGUGGGGGCUGGGGUAGACUCCCCUGGAGCCAAGCCUAUCCAGCUAACAAGAGCUCCCUGGGGCUGGUCACAGCUGGCUCAUGAUGCUGAACUUGAAAGUUUUUUUGUUUUUGUUUUUGUUUUGUGGCUCCUCCAAGAUAUAGGUACAUGAAGUUUAGGUUAAAGGGGUGGGAUUCUUUAUUUUUAUUUUUGUAUUGUAUGUGUCAAGAAUUACUCUGUUGUUCACCUUUUGCUUUUUGCACUGUUUGUUCUCUUAUCUGUAUUUUGAGCUUAGUGCUAGGACUGAGAGGCUGCACCAUAGGGAAUGUAUGGGAGAUGGUGAGGGGUGCCAGUGAGGGGUGCGUGGAGGAGAGGCCUGGGCUCCUCUACUGGAUCUACACUCUGUCCCAGGUUUUUAGAUCCCACUGAGCCCAGCUGACUGAAAACAAGGACAGUCAGGGUGAAACUUCUUUUGCCAGAAGUGUGGCCUGAGUUGAAUUUCUGGGAGGAUGACGCAGAUGUCUGCUGCAGAGCUGGGCUGAGAGUUCUGCAGUCUAGCUCUGACUUAGGUCAGGGGCCUGUUGGUCUCUCAUUGGACGUUUUUGGGUCUCACUCAUGCUUACUGAAACAUUGUGCCAAGAAACUCUGUGGGAUUUGUGUCCCUUAAACCAGACUCACUUUUCUGAAAAAUCUCCAUUGUUGAGGAGAGGCUGCUCAAUCGACACCCCGAGUUCUCAUGACUGGGAAGAUAGUUUUCUUCAGGUGUCAAUGGCGUUAGACUCCCAGGAAGACUAGCCCUGCCCACAGGGCCACCUGUUGGUUUGAGAGCGUGUUCGUGUUCUCUUGCCCUCCCUGCCUAAGAGCUACUGGGAUCACGUUAGCGGGCAUUUAGGCUUUGAUGAGAGGGCACAGUUUGAGUUAGGUUUACCUCCCCCUUUCUGUGCCUGGGAACUGUUUGGUCCAGCUUUAGAACUGUGGUUUUGACUUCCUUAUCUCUUGGGAGAAGCUUCUGUUUUAAGGAAUUUCUCUUCCUUCUUCUCCUGCCUCUAGCCUCUCCUGGAAAGGCCUGGAUAUGGUUUCUAAAAUCUCAGCUGAGAACUUCAGAAAACAGCAGCAGUAUUUUCCUUUUCCUAGUGCUAAAAUCCCUUUCCCUAGAAAUUGGCUCACCUUGGGAAACCCAGGGAAAGAAUCAGCAGGUUCUCUGCCCUCCCUAGGGGUUGGGGAAGGACCCACCCCGGUCAGCACAGUGCCUUUUCCUCUCCUGCUCUGAGCCAGGGUGGGGCAUUCCCUCUAGAUUCAGGUUUGGGCAGGGGUCCUAUAGUCCCUGCCAUGGGGCUGCUUCCCUGUCCCUUCCCUCCCCUUUGCUGGCCUACUCUGGCAUAAUUCAAGUGUCUUCUUGCCUUGGGGAUCCUUAGUGGCAUCAAAUGGCAACAUGGAAUAUUGUCCUCCAUGCCCCUCCAGAAGGACCUAGGAGAGUAGGUGAGCUUUCCAAAGUGAGAGACGAAUCUUUCUUUCUUUUUUUUUUUAAAGGGCAGGAUGGGUAUGCUUUGGGCUUUCUCCUUCUGUGGCCCCGGAGGAAGGAGAGACUGAGGCAAGGCAAAGUGAUAGUACACGGAAGCAGAACCGGAAACACCCAGGAACUGUUCAGAAAUCUCAGAAGAAAUCUGCUUCUCUUCGAUGGAAAGAUAUAAUUAACGAUCAAAGAGCUCUAAGAAAAUUGCAAAGAAGCCUUAAUGUUCAAGCUUUAGAAAGAUCAGAGCAAUUUUUCUCUUUCAGUCCAAACUAAGACUCUCUGUAUUUAAAUCUCUCUGGGGCAAGAGGGCUAGAUUUCCUCAUUUUGUUAUGAGACUAGAUUGGUACCAGUAGAUCAGCUGCCUAGCGAGGGCAGGUUUCUUCUUUGCAUCUGUGUGGCUUGCUUCCAGUCUGGCCUGUCCUUUCCAGCUGCCUUUUGUCUAGCCUGCUAUGGGGGGCCAGAUUAUCUUGAUAAGAGCAGGUGAUUUGGGGACUAGCUGGGUUGGCAGGAAAAGAGCAGGAUGGAUCUCUUGGGACAGGUUCCCCCAGGAGUAUAAACACAAGGAGCCAGGAUUGUGCUGGCAGCCAAGGAAACAGUAGUGCCUGUUUGAGUUGGCAGAGAGGGCCUUGGCACCUCUUGCAUCCAGGCAGUCUUGUGAGAUGGGGGCACAUAGCACUGGGGAAAGCAGAACUCCAUUCUCACCUCUAUUUUGAGCUUCAGUGCUUUAUUUCAGUAUGAGGAAAAACAACAACAAACUGAAGUGCGCUUUCCGUCCUUUCAAAGGACAACUGUCGGGAAGGGAGAGCCGAGUUGCGAGGUAGGAGGGGAGCACUGGCAGGGAGAGACAUUCUUGACUCCUCUCUUCCCUGGUGUGUUGUGAUCCAGGGAAUGAAAAGAAAUUUGACCCUGGAUUGGUUCUCUCCUUGGACUUAAGGAAUCUUACCUUUUCCUUCCACAAAGUUCUCCCAGGCAAGGACCAGCUGCCCAUUCUGAGCCCAGGGCAGCCUCUUCAACCAUUAUUGGUCUAACCUGGCUUGUCAGGAAACCAAGCCCACCCUUCCACAUUGGGCCUGGCUGCUCUAUUCUGUACCAAGUACUGGAGAAAAAGCAUCAAGUUCUUAGCCCUUGUAGCUUCUACCCUAGUUUCCCAUCCUCUCUCUGUGGAGGCCAAACCAACUCUUUGCCAGCAGCCACAACAUGCAUUGACAGCGGCACAGUGAGAUAUAACUGAUGGGCUUUGAACCUGGUUGGCCGGGGAAGCUGUAGGGGUGGAUAGAGCUGGCUUUCCUUCUGGGCUGUCUCCAUCUGACCCUACCCCUUCCAUGUCCCACCCCACUCCCACCAAAAAGUACAAAAUCAGGAUGUUUUUCACUGUCCAUUGCUUUGUGUUUUAAUAAACAAUUUGCAGUGACA-3'- Poly-A tail
  • Coding region
;
DNA
DNA (Gene ID: 9761)
malectin
strand +
NCBI CDS gene sequence (879 bp)
5'-ATGCTGGGAGCCTGGGCGGTTGAGGGAACCGCTGTGGCGCTCCTGCGACTGCTGCTGCTGCTGCTGCCGCCGGCGATCCGGGGACCCGGGCTCGGCGTGGCCGGCGTGGCCGGCGCGGCGGGGGCCGGGCTGCCCGAGAGCGTCATTTGGGCGGTCAACGCGGGTGGAGAGGCGCATGTGGACGTGCACGGGATCCACTTCCGCAAGGACCCTTTGGAAGGCCGGGTGGGCCGAGCCTCAGACTATGGCATGAAACTGCCAATCCTGCGTTCCAACCCTGAGGACCAGATCCTGTATCAAACTGAGCGGTACAATGAGGAGACCTTTGGCTACGAAGTGCCCATCAAAGAGGAGGGGGACTACGTGCTGGTCTTGAAATTTGCAGAGGTCTACTTTGCACAGTCCCAGCAAAAGGTATTTGATGTACGATTGAATGGCCACGTCGTGGTGAAGGACTTGGATATCTTTGATCGTGTTGGGCATAGCACAGCTCACGATGAAATTATACCTATGAGCATCAGAAAGGGGAAGCTGAGTGTCCAGGGGGAGGTGTCCACCTTCACAGGGAAACTCTACATTGAGTTTGTCAAGGGGTACTATGACAATCCCAAGGTCTGTGCACTCTACATCATGGCTGGGACAGTGGATGATGTACCAAAGCTTCAGCCTCATCCGGGATTGGAGAAGAAAGAAGAGGAAGAAGAAGAAGAAGAATATGATGAAGGGTCTAATCTCAAAAAACAGACCAATAAGAACCGGGTGCAGTCAGGCCCCCGCACACCCAACCCCTATGCCTCGGACAACAGCAGCCTCATGTTTCCCATCCTGGTGGCCTTCGGAGTCTTCATTCCAACCCTCTTCTGCCTCTGCCGGTTGTGA-3'
NCBI CDS gene sequence with introns (location: 120687297.. 120696545) (9249 bp)Download
NCBI CDS gene sequence with introns, 5'UTR and 3'UTR (location: 120687149.. 120701859) (14711 bp)Download
NCBI gene sequence (location: [120687149 - 1000].. 120701859) (15711 bp)Download
How to cite: Schnider B., M'Rad Y., el Ahmadie J., de Brevern AG., Imberty A., Lisacek F., HumanLectome, an update of UniLectin for the annotation and prediction of human lectins, Nucleic Acids Reasearch doi.org/10.1093/nar/gkad905